ClinicalTrials.Veeva

Menu

Supervised Treadmill Intervention to Reduce Inflammation and Depression Through Exercise in HIV: The STRIDE Pilot Study

University of Minnesota (UMN) logo

University of Minnesota (UMN)

Status

Completed

Conditions

Depression
Hiv

Treatments

Behavioral: Supervised exercise
Behavioral: upfront advice to walk

Study type

Interventional

Funder types

Other

Identifiers

NCT06149624
MED-2023-32453

Details and patient eligibility

About

Depression in people living with HIV is associated with worse care engagement, drug adherence, and higher rates of pre-mature mortality. The prevalence of depression is three times greater in those with HIV than comparable controls. While antiretroviral therapy (ART) enables immune reconstitution, those with depression do worse clinically than those without depression even when controlling for HIV stage. However, treating depression in HIV-infected persons is challenging. Even among those virologically suppressed on ART, a significant percentage are resistant to standard pharmacotherapy or psychotherapy for depression. The reasons for this are complex and poorly understood. An emerging body of evidence indicates that inflammation may perpetuate depression. Given people with HIV have ongoing increased inflammation, this could help explain part of why depression rates are so high in people with HIV.

Treatments for HIV-associated depression would likely be more effective if they were anti- inflammatory in nature. One possible treatment is exercise. Exercise is acutely pro-inflammatory due to catabolism but in the long term is anti-inflammatory. However, few studies have investigated exercise as a treatment for HIV-associated depression. The study objective is to perform a feasibility study to evaluate a larger trial evaluating the efficacy of exercise as an intervention for depression in people with HIV.

Enrollment

22 patients

Sex

All

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Enrolled in Mildmay HIV clinic
  • Adults 18-45 years old
  • HIV positive
  • Receiving HIV therapy
  • HIV viral suppression (<400 copies/mL) per chart review
  • Mild to Moderate (PHQ9 score >5 but >20)
  • Not currently engaged in a formal exercise program or manual labor such as construction or delivery requiring a manual bike or walking
  • Able to walk/run on a treadmill
  • Informed consent

Exclusion criteria

  • Women pregnant or breastfeeding
  • Suicidal (PHQ-9 question 9 score >2) or Severely Depressed (PHQ-9 score >20)
  • Uncontrolled hypertension (≥180 systolic or ≥100 diastolic blood pressure)
  • Lower limb orthopedic limitations (e.g. amputations, arthritis)
  • Resting heart rate >90/min
  • Known atherosclerotic or non-atherosclerotic peripheral artery disease.
  • Exercise intolerance due to other known medical condition(s) which may make it unsafe for the patients to participate in.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

22 participants in 2 patient groups, including a placebo group

control
Placebo Comparator group
Description:
participants randomized to control group
Treatment:
Behavioral: upfront advice to walk
Intervention group
Experimental group
Description:
participants randomized to intervention group
Treatment:
Behavioral: Supervised exercise

Trial contacts and locations

1

Loading...

Central trial contact

Sarah Lofgren, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems